PET/CT imaging in treatment planning and surveillance of sinonasal neoplasms

S Akay, JH Pollard, A Saad Eddin, A Alatoum… - Cancers, 2023 - mdpi.com
Simple Summary Sinonasal cancers are rare types of cancer that are often detected at a late
stage, making them difficult to treat. To monitor these cancers closely, advanced imaging …

Molecular imaging and therapy of somatostatin receptor positive tumors

J Ivanidze, M Roytman, A Sasson, M Skafida… - Clinical Imaging, 2019 - Elsevier
Somatostatin receptors (SSTR) are upregulated in the cells of origin that define numerous
neuroendocrine neoplasms. PET imaging with 68 Ga-DOTATATE allows specific targeting of …

SSTR2 expression in olfactory neuroblastoma: clinical and therapeutic implications

V Cracolici, EW Wang, PA Gardner… - Head and Neck …, 2021 - Springer
Abstract Somatostatin receptor 2 (SSTR2) expression has previously been documented in
olfactory neuroblastoma (ONB). Here, we fully characterize SSTR2 expression in ONB and …

Efficacy of peptide receptor radionuclide therapy for esthesioneuroblastoma

OK Hasan, ASR Kumar, G Kong… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Esthesioneuroblastoma is rare, with limited therapeutic options when unresectable or
metastatic; however, expression of somatostatin receptors qualifies it for peptide receptor …

Somatostatin receptor 2 is highly sensitive and specific for Epstein-Barr virus–associated nasopharyngeal carcinoma

K Viswanathan, PM Sadow - Human pathology, 2021 - Elsevier
Viruses are known drivers of head and neck squamous cell carcinomas (HNSCC),
particularly Epstein-Barr virus (EBV) and human papillomavirus (HPV). Both EBV-positive …

The value of 68Gallium‐DOTATATE PET/CT in sinonasal neuroendocrine tumor management: A case series

KY Liu, DY Goldrich, SJ Ninan, A Filimonov… - Head & …, 2021 - Wiley Online Library
Abstract Background 68Gallium‐DOTATATE (68Ga‐DOTATATE) is a somatostatin analog
used as a PET tracer to successfully identify neuroendocrine tumors (NETs). Due to the rarity …

Neuroblastoma xenograft models demonstrate the therapeutic potential of 177Lu-octreotate

A Romiani, J Spetz, E Shubbar, DE Lind, B Hallberg… - BMC cancer, 2021 - Springer
Background Neuroblastoma (NB) is one of the most frequently diagnosed tumors in infants.
NB is a neuroendocrine tumor type with various characteristics and features, and with …

[68Ga]-DOTATATE PET/CT and PET/MRI in the diagnosis and management of esthesioneuroblastoma: illustrative cases

M Roytman, AB Tassler, A Kacker, TH Schwartz… - … of Neurosurgery: Case …, 2021 - thejns.org
BACKGROUND Esthesioneuroblastoma (ENB), also known as olfactory neuroblastoma, is a
rare sinonasal neuroectodermal malignancy with a slow onset of symptoms, favorable 5 …

[HTML][HTML] Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma

M Lechner, Y Takahashi, M Turri-Zanoni, J Liu… - European Journal of …, 2022 - Elsevier
Introduction Olfactory neuroblastoma (ONB) is a rare cancer of the sinonasal region. We
provide a comprehensive analysis of this malignancy with molecular and clinical trial data …

Olfactory neuroblastoma: treatment strategies for advanced disease

LP Carlstrom, JJ Van Gompel, G Choby - Current Otorhinolaryngology …, 2023 - Springer
Abstract Purpose of Review This review seeks to synthesize emerging literature and expert
management recommendations of olfactory neuroblastoma (ONB), a rare sinonasal …